Clinical trials
Phase 2 Nervous System Diseases trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2017 | 2 |
| 2018 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Terminated | 2 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroscience Trials Australia | 3 |
| GlaxoSmithKline | 2 |
| Inmune Bio, Inc. | 2 |
| AbbVie | 1 |
| Alkahest, Inc. | 1 |
| Emerald Health Pharmaceuticals | 1 |
| Takeda | 1 |
| Vertex Pharmaceuticals Incorporated | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nervous System Diseases | 12 |
| Brain Diseases | 9 |
| Central Nervous System Diseases | 9 |
| Dementia | 6 |
| Alzheimer Disease | 5 |
| Mental Disorders | 5 |
| Neurodegenerative Diseases | 5 |
| Cardiovascular Diseases | 3 |
| Cerebrovascular Disorders | 3 |
| Neurocognitive Disorders | 3 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.